Seminars in Oncology
Volume 30, Issue 2 , Pages 142-145, April 2003

Genetics and cytogenetics of Waldenstrom's macroglobulinemia☆☆

Mayo Clinic, Department of Hematology and Internal Medicine, Rochester, MN.

Abstract 

Waldenstrom's macroglobulinemia (WM) is a clonal B-cell disorder characterized by the production of a monoclonal paraprotein and lymphoplasmacytic clonal expansion. The genetic basis of this disorder is poorly understood. We have recently found that the genetic makeup of WM cells is different from that commonly reported for multiple myeloma (MM), follicular lymphoma, and B-cell chronic lymphocytic leukemia. Translocations involving the immunoglobulin heavy chain locus (IgH) translocations could not be detected in any case, and a molecular analysis showed that the IgH locus switch μ retained its germline configuration. Aneuploidy was not detected using chromosome enumeration probes. The only recurrent chromosome abnormality found was deletion of 6q21. The lack of legitimate of illegitimate rearrangements at the IgH locus suggests that other mechanisms are involved in the pathogenesis of the disorder. Given the clear evidence of a familial form of WM and the currently presumed genomic stability of the clonal cells, it is likely that a single gene defect may be responsible for disease pathogenesis. Having found deletions of the long arm of chromosome 6 as the only recurrent aberration, we speculate that a gene involved in B-cell maturation or survival at this locus may be inactivated as a cause of WM. Semin Oncol 30:142-145. © 2003 Elsevier Inc. All rights reserved.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 R.F. is supported by a research grant from the International Waldenstrom Macroglobulinemia Foundation. R.F. is a Clinical Investigator of the Cancer Research Fund of the Damon Runyon Foundation. This work was also supported in part by Public Health Service Grant No. R01 CA83724-01 from the National Cancer Institute (R.F.).

☆☆ Address reprint requests to Rafael Fonseca, MD, Division of Hematology and Internal Medicine, Stabile 628, Rochester, MN 55905.

 0093-7754/03/3002-0040$30.00/0

PII: S0093-7754(03)70065-7

doi:10.1053/sonc.2003.50075

Seminars in Oncology
Volume 30, Issue 2 , Pages 142-145, April 2003